在激素受体阳性HER2阴性乳腺癌中,MAP3K1突变赋予瘤免疫异质性
Yu-Wen Cai1,2, Cui-Cui Liu1,2, Yan-Wu Zhang3
1Department of Breast Surgery, Fudan University Shanghai Cancer Center and Cancer Institute, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
The Journal of clinical investigation
|November 12, 2024
概括
在激素受体阳性乳腺癌中发生的基激酶激酶1 (MAP3K1) 突变会导致免疫逃避. 后生物胺可以逆转这种情况,提高免疫治疗的有效性.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 遗传学 遗传学 是一个
背景情况:
- 激素受体阳性/人表皮生长因子受体2-阴性 (HR+/HER2-) 乳腺癌是最常见的亚型,表现出内分泌疗法耐药性和远程复发等挑战.
- 虽然免疫疗法在三阴性乳腺癌中表现有前途,但其在HR+/HER2-乳腺癌中的应用需要进一步的免疫学研究.
研究的目的:
- 为了研究HR+/HER2-乳腺癌的免疫异质性.
- 确定与这种异质性相关的生物标志物并阐明潜在的机制.
- 探索新的治疗策略,以提高这种亚型的免疫疗法疗效.
主要方法:
- 对351名HR+/HER2-乳腺癌患者的队列进行了多组组的分析.
- 实验验证MAP3K1突变对抗瘤免疫的影响.
- 研究MAP3K1突变在MHC-I抗原呈现和TAP1/2mRNA降解中的作用.
- 提拉胺作为治疗干预的临床前测试.
主要成果:
- HR+/HER2-乳腺癌表现出显著的瘤免疫微环境异质性.
- 同位素激活蛋白激酶激酶1 (MAP3K1) 突变与这种免疫异质性有关.
- MAP3K1突变通过通过TAP1/2mRNA降解抑制MHC-I呈现来减弱CD8+T细胞介导免疫力,促进免疫逃逸.
- 在临床前模型中,后生物胺逆转了MAP3K1突变诱导的MHC-I减少,提高了免疫治疗的疗效.
结论:
- MAP3K1突变是HR+/HER2-乳腺癌免疫异质性的关键驱动因素.
- MAP3K1突变通过受损的抗原呈现促进瘤免疫逃生.
- 提拉胺为克服MAP3K1驱动的免疫逃避和增强免疫治疗提供了一个有前途的新疗法策略.
更多相关视频
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
2.6K
11:34Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
Published on: December 5, 2017
12.6K
相关概念视频
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Mismatch Repair
4.8K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.8K
